{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:43:43Z","timestamp":1792035823579,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.diabres.2025.112476","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:53:50Z","timestamp":1757440430000},"page":"112476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effect of daily insulin delivery variability on glycemic outcomes in patients with type 1 diabetes mellitus using an automated insulin delivery system"],"prefix":"10.1016","volume":"229","author":[{"given":"Giuseppe","family":"Papa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4599-8487","authenticated-orcid":false,"given":"Rossella","family":"Cannarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Gusmano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Anzaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Gruttadauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella Lo","family":"Presti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Scir\u00e8","family":"Calabrisotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita A.","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"La Vignera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112476_b0005","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes-2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S146-S166. 10.2337\/dc25-S007. Erratum in: Diabetes Care. 2025 Apr 1;48(4):666. 10.2337\/dc25-er04b. PMID: 39651978; PMCID: PMC11635043.","DOI":"10.2337\/dc25-er04b"},{"key":"10.1016\/j.diabres.2025.112476_b0010","unstructured":"Linea Guida della Associazione dei Medici Diabetologi (AMD), della Societ\u00e0 di Diabetologia (SID) e della Societ\u00e0 Italiana di Endocrinologia e Diabetologia Pediatrica (SIEDP). La terapia del diabete mellito di tipo 1. Versione aggiornata a gennaio 2024. https:\/\/www.iss.it\/-\/snlg-diabete-mellito-tipo1."},{"issue":"6","key":"10.1016\/j.diabres.2025.112476_b0015","doi-asserted-by":"crossref","first-page":"e3842","DOI":"10.1002\/dmrr.3842","article-title":"Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in people with Type 1 Diabetes: a Systematic Review and Network Meta-Analysis","volume":"40","author":"Di Molfetta","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.diabres.2025.112476_b0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus Recommendations for the use of Automated Insulin delivery Technologies in Clinical Practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"issue":"S3","key":"10.1016\/j.diabres.2025.112476_b0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/dia.2023.0433","article-title":"Celebrating the Data from 100,000 Real-World users of the MiniMed\u2122 780G System in Europe, Middle East, and Africa Collected over 3 Years: from Data to Clinical evidence","volume":"26","author":"Choudhary","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.diabres.2025.112476_b0030","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/dom.14714","article-title":"Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: evidence from 12 870 real-world users","volume":"24","author":"Arrieta","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112476_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110907","article-title":"Glycometabolic outcomes in adult type 1 diabetic patients switching to closed-loop systems","volume":"204","author":"Papa","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10.1016\/j.diabres.2025.112476_b0040","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.2337\/dc22-1217","article-title":"Biobehavioral changes following transition to Automated Insulin delivery: a Large Real-life Database Analysis","volume":"45","author":"Kovatchev","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112476_b0045","doi-asserted-by":"crossref","unstructured":"Breton MD, Kovatchev BP. One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology. Diabetes Technol Ther. 2021 Sep;23(9):601-608. 10.1089\/dia.2021.0097. Epub 2021 Apr 21. PMID: 33784196; PMCID: PMC8501470.","DOI":"10.1089\/dia.2021.0097"},{"issue":"6","key":"10.1016\/j.diabres.2025.112476_b0050","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/dom.15008","article-title":"One-year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes in Germany","volume":"25","author":"Benhamou","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112476_b0055","doi-asserted-by":"crossref","unstructured":"Alwan H, Wilinska ME, Ruan Y, Da Silva J, Hovorka R. Real-World Evidence Analysis of a Hybrid Closed-Loop System. J Diabetes Sci Technol. 2025 Mar;19(2):385-389. 10.1177\/19322968231185348. Epub 2023 Jul 8. PMID: 37421250; PMCID: PMC11873883.","DOI":"10.1177\/19322968231185348"},{"issue":"8","key":"10.1016\/j.diabres.2025.112476_b0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/dia.2023.0578","article-title":"Real-World evidence of Omnipod\u00ae5 Automated Insulin delivery System Use in 69,902 people with Type 1 Diabetes","volume":"26","author":"Forlenza","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"S3","key":"10.1016\/j.diabres.2025.112476_b0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/dia.2023.0446","article-title":"A Peek under the Hood: explaining the MiniMed\u2122 780G Algorithm with Meal Detection Technology","volume":"26","author":"Grosman","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.diabres.2025.112476_b0070","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/dom.14396","article-title":"Day-to-day variability of insulin requirements in the inpatient setting: Observations during fully closed-loop insulin delivery","volume":"23","author":"Boughton","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.diabres.2025.112476_b0075","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2337\/dc15-2623","article-title":"AP@home Consortium. Variability of Insulin Requirements over 12 Weeks of Closed-Loop Insulin delivery in adults with Type 1 Diabetes","volume":"39","author":"Ruan","year":"2016","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2025.112476_b0080","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1007\/s00125-024-06165-w","article-title":"The role of automated insulin delivery technology in diabetes","volume":"67","author":"Boughton","year":"2024","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.diabres.2025.112476_b0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4158\/EP-2018-0515","article-title":"REAL-WORLD IMPLICATIONS OF HYBRID CLOSE LOOP (HCL) INSULIN DELIVERY SYSTEM","volume":"25","author":"Faulds","year":"2019","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.diabres.2025.112476_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2022.0421","article-title":"Adult and Pediatric MiniMed\u2122 HCL Outcomes 6-month RCT: HCL versus CSII Control Study Group. improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin infusion Therapy: results from a Randomized Controlled Trial","volume":"25","author":"Garg","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.diabres.2025.112476_b0095","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13300-023-01394-5","article-title":"A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin delivery Systems","volume":"14","author":"Peacock","year":"2023","journal-title":"Diabetes Ther"},{"issue":"7","key":"10.1016\/j.diabres.2025.112476_b0100","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/dc18-2625","article-title":"APCam11, AP@Home, and KidsAP Consortia. Young Children have Higher Variability of Insulin Requirements: Observations during Hybrid Closed-Loop Insulin delivery","volume":"42","author":"Dovc","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2025.112476_b0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/19322968221106194","article-title":"Insulin Requirements for Basal and Auto-Correction Insulin delivery in Advanced Hybrid Closed-Loop System: 4193 days' Real-World Data of Children in two Different Age groups","volume":"18","author":"Karaku\u015f","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2025.112476_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112173","article-title":"The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy","volume":"224","author":"Tumminia","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2025.112476_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.766314","article-title":"Six-month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents with Type 1 Diabetes Mellitus","volume":"12","author":"Tornese","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.diabres.2025.112476_b0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/19322968231185115","article-title":"Real-World Performance of First- Versus Second-Generation Automated Insulin delivery Systems on a Pediatric Population with Type 1 Diabetes: a One-Year Observational Study","volume":"19","author":"Bombaci","year":"2025","journal-title":"J Diabetes Sci Technol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725004905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725004905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:18:32Z","timestamp":1764080312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725004905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":24,"alternative-id":["S0168822725004905"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112476","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of daily insulin delivery variability on glycemic outcomes in patients with type 1 diabetes mellitus using an automated insulin delivery system","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112476"}}